Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,179) with videos related to
Page
of 118
Sort By:
Thrombosis and Haemostasis
|
December 7, 2017
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
Andria Medina, Gary Raskob, Walter Ageno, et al.
Circulation
|
April 7, 2022
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials
Alex C Spyropoulos, Gary E Raskob, Alexander T Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
Maria A de Winter, Alicia Uijl, Harry R Büller, et al.
The American Journal of Medicine
|
April 17, 2018
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy
Gerald Chi, C Michael Gibson, Adrian F Hernandez, et al.
British Journal of Haematology
|
May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes
Susan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
BMC Primary Care
|
January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers
Kevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
May 3, 2025
ILAE neuroimaging task force highlight: MRI detection of early life epilepsy caused by focal cortical dysplasia
Nathan T Cohen, L Gilbert Vezina, Chima Oluigbo, et al.
Thrombosis Research
|
December 18, 2017
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial
Thomas Vanassche, Peter Verhamme, Philip S Wells, et al.
Thrombosis Research
|
August 2, 2018
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin
Paolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Blood Advances
|
December 4, 2019
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Robert I Liem, Sophie Lanzkron, Thomas D Coates, et al.
Page
of 118
Search research articles
Search
Showing results (1121-1130 of 1,179) with videos related to
Sort By:
Page
of 118
Thrombosis and Haemostasis
|
December 7, 2017
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
Andria Medina, Gary Raskob, Walter Ageno, et al.
Circulation
|
April 7, 2022
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials
Alex C Spyropoulos, Gary E Raskob, Alexander T Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
Maria A de Winter, Alicia Uijl, Harry R Büller, et al.
The American Journal of Medicine
|
April 17, 2018
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy
Gerald Chi, C Michael Gibson, Adrian F Hernandez, et al.
British Journal of Haematology
|
May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes
Susan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
BMC Primary Care
|
January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers
Kevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape
|
May 3, 2025
ILAE neuroimaging task force highlight: MRI detection of early life epilepsy caused by focal cortical dysplasia
Nathan T Cohen, L Gilbert Vezina, Chima Oluigbo, et al.
Thrombosis Research
|
December 18, 2017
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial
Thomas Vanassche, Peter Verhamme, Philip S Wells, et al.
Thrombosis Research
|
August 2, 2018
Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin
Paolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Blood Advances
|
December 4, 2019
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease
Robert I Liem, Sophie Lanzkron, Thomas D Coates, et al.
Page
of 118